Newsroom

RIYADH, Saudi Arabia--(BUSINESS WIRE)--Recently, Changan Automobile held the national qualifying rounds of the 2nd CHANGAN Middle East & Africa (MEA) Service Skills Competition across four key markets: Saudi Arabia, Kuwait, Egypt, and Oman. The competitions drew around 60 service professionals from over 40 authorized outlets, with the top performers advancing to the Regional Final. With over 40 years of market presence, Changan Automobile has established itself as the top-selling Chinese au...

NEW YORK & LONDON--(BUSINESS WIRE)--General Atlantic, a leading global investor, today announced that Novak Djokovic is joining the firm as Global Strategic Advisor. One of the most accomplished athletes in history and a global advocate for high performance and wellness, Mr. Djokovic will work closely with the firm's leadership, portfolio companies, and investors, bringing perspectives on leadership, resilience, and innovation that reflect General Atlantic's commitment to excellence. As Global...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...

ABU DABI, Emiratos Árabes Unidos--(BUSINESS WIRE)--Burjeel Holdings, grupo líder en atención médica de alta especialización del Consejo de Cooperación del Golfo (CCG) que cotiza en la Bolsa de Valores de Abu Dabi, estableció el precio de su primera emisión de Sukuk senior no garantizada a 5 años bajo la Regulación S, por un valor de $500 millones, con vencimiento en 2031, en el marco de su programa de Sukuk Senior No Garantizado recientemente establecido por valor de $1500 millones. La oferta a...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today announced that Founder, Chairman, and CEO J.W. Roth was featured in an in-depth interview with executive publisher and host Dirk Hobbs, CEO of Colorado Media Group, on The Business Digest Radio Show & Podcast; the radio and podcast outreach of the Southern Colorado Business Digest. In the conve...

TOKYO--(BUSINESS WIRE)--Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sanky...

OLDWICK, N.J.--(BUSINESS WIRE)--A pair of distinct sub-markets have evolved within the U.S. cyber insurance space, one dominated by surplus lines carriers writing primary and excess cyber-specific policies and the other focused on endorsements to commercial policies, according to a new AM Best report. The results between the two vary, with third-party claims growing more rapidly within the surplus lines side of the market.The combined overall premiums generated from cyber insurance coverage incr...